Pickleball Boom Nets New Healthcare Opportunities

Pickleball’s popularity has led to a rise in injuries and associated medical costs in the US. However, some healthcare organizations are now partnering with the pickleball community to provide injury prevention education, care, and build lasting relationships with players. For example, the Cedars-Sinai Kerlan-Jobe Institute in Los Angeles and Humana have formed partnerships with the…

Read More

Best Shampoo For Oily Hair In 2024: Say Goodbye To Grease

Having oily hair can be uncomfortable and erode self-confidence, but proper hair care routines and the right shampoo can help manage and balance oily hair. Some of the best shampoos for oily hair include Neutrogena T/Sal Therapeutic Shampoo, L’Oreal Paris Elvive Extraordinary Clay Rebalancing Shampoo, Aveeno Scalp Soothing Apple Cider Vinegar Blend Shampoo, Paul Mitchell…

Read More

Deucravacitinib safer and more effective than apremilast for treating moderate to severe scalp psoriasis

A study has found that deucravacitinib is both safer and more effective than apremilast for treating moderate to severe scalp psoriasis. These findings suggest that deucravacitinib may be a promising treatment option for individuals with this condition. The study’s results provide valuable information for healthcare providers and patients seeking effective treatments for scalp psoriasis. This…

Read More

Coordination of Benefits: An Overlooked Pillar of Medicaid Programs

Medicaid is a vital healthcare safety net in the U.S., with $824 billion in spending in 2022. One important but lesser-known aspect is the coordination of benefits, which ensures efficient management of funding sources and prevents overutilization of services. This practice also maximizes financial resources, promotes fair distribution of resources, and mitigates fraud and abuse….

Read More

SGLT-2i and GLP-1RA Combination Therapy Reduces Adverse Cardiovascular Events

Combining sodium-glucose cotransporter-2 inhibitor (SGLT-2i) and glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy is associated with a lower incidence of cardiovascular events in patients with type 2 diabetes and a recent acute myocardial infarction. The study found that the combination therapy had a reduced incidence of major adverse cardiovascular events compared to either therapy alone. The…

Read More

Navigating Healthcare Software with Cerner and Epic EMR

The article provides an analysis of the Cerner and Epic EMR healthcare software platforms, outlining their features, pros and cons, and pricing. Cerner EMR, owned by Oracle, offers an adaptable, integrated solution for healthcare organizations, catering to various specialties and providing valuable resources for patient care. However, it may have navigation issues and limited capabilities…

Read More

The latest on Novavax, Merck, Bluebird

In biotech news, Merck reported strong fourth-quarter earnings and a forecast for 2024 sales with an increase of 6%, while Roche and Sanofi also reported their earnings. The biotech industry is affected by the Federal Reserve’s decision not to cut interest rates, causing a 2% dip in the XBI index. Bluebird Bio’s financial results will…

Read More
error: Content is protected !!